Showing 71-80 of 353 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Advanced Oxygen Generator for Oxygenated Cell Capsules | Giner, Inc. | Linda Tempelman | Cures | 01-June-2021 to 30-September-2026 | $448.173,29 |
| Creation of a Commercializable Multi-Omics Resource from T1D Patient-Derived iPSC-Derived 3D Islet Organoid Models | Greenstone Biosciences, Inc. | Angelos Oikonomopoulos | Cures | 25-June-2026 to 24-June-2029 | $1.200.000,00 |
| T1D Cures Accelerator | Health and Environmental Sciences Institute: Home – HESI | Syril Pettit | Cures | 01-October-2026 to 30-September-2029 | $1.499.197,46 |
| Goals of Care Among Caregivers of Youth with T1D Using The 3-Act Model | Hugo W. Moser Research Institute at Kennedy Krieger | Karen Dimentstein | Transportfolio | 01-September-2024 to 31-August-2026 | $128.399,18 |
| Development and Preclinical Assessment of a Biovascular Pancreas | Humacyte | Kaleb Naegeli | Cures | 01-April-2023 to 28-February-2027 | $863.333,00 |
| Bringing Beta Cell Regenerative Therapy to the Clinic | Icahn School of Medicine at Mount Sinai | Andrew Stewart | Cures | 01-January-2024 to 31-December-2026 | $1.000.000,00 |
| Exploring the Effects of Beta Cell Regenerative Drugs on Cell Fate Decisions in Human Pancreatic Islets | Icahn School of Medicine at Mount Sinai | Esra Karakose | Cures | 01-March-2025 to 28-February-2030 | $999.999,00 |
| Targeting pathogenic Th17 cells as shared mechanisms in MS, SLE and T1D | Icahn School of Medicine at Mount Sinai | Ka Lung Cheung | Cures | 01-September-2026 to 31-August-2027 | $149.950,03 |
| Enhancing Functional Maturation of Stem Cell-Derived Beta Cells Using Harmine for Improved Diabetes Therapy | Icahn School of Medicine at Mount Sinai | Peng Wang | Cures | 01-July-2025 to 31-December-2026 | $305.000,00 |
| Protective Genetic and Pharmacological Interventions to Prevent Cytokine and Autoimmune-based Destruction of β cells. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-April-2025 to 31-March-2027 | $559.996,54 |